Novo launches oral Wegovy for obesity in Spain
Novo Nordisk introduces the first daily oral GLP-1 pill for weight management in Spain following European Commission approval.
#SpainHealth
Novo launches oral Wegovy for obesity in Spain · Spain expects 38,318 breast cancer cases in 2026 · Spain warns of menopause drug shortage extension
Spain expects 38,318 breast cancer cases in 2026
The Spanish Society of Medical Oncology reports rising incidence among younger women as the national screening age is lowered to 45.
Spain warns of menopause drug shortage extension
The Aemps alerts that Lenzetto and Evopad supply issues could persist past November 2026 due to manufacturing problems and high demand.